Company news
Orthofix Medical Inc. news in 2022
Orthofix Medical Inc.'s news releases, calls and decks from 2022, newest first.
Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures
December 21, 2022
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing
November 17, 2022
Orthofix Medical Announces Participation in Upcoming Stifel Healthcare Conference
November 9, 2022
Orthofix Reports Third Quarter 2022 Results
November 2, 2022
Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022
October 24, 2022
Orthofix Announces First Patient Implants with Legacy Demineralized Bone Matrix for Spine, Pelvic and Extremities Procedures
October 12, 2022
Orthofix and MTF Biologics Recognized with 2022 Spine Technology Award for Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
October 11, 2022
Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results
October 10, 2022
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company
October 10, 2022
Orthofix Announces Presentation of Long-Term Evidence Highlighting the Clinical Management of Cervical Disc Arthroplasty at North American Spine Society Annual Meeting
October 9, 2022
Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference
September 13, 2022
Orthofix Reports Second Quarter 2022 Results
August 4, 2022
Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions
August 1, 2022
Orthofix Medical Schedules Second Quarter Earnings Release and Conference Call for August 5, 2022
July 26, 2022
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
July 25, 2022
Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market
July 12, 2022
Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years
May 30, 2022
Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference
May 15, 2022
Orthofix Reports First Quarter 2022 Results
May 5, 2022
FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions
May 3, 2022
Orthofix and MTF Biologics Expand Partnership Agreement
May 2, 2022
Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022
April 27, 2022
Orthofix Announces New Business Unit President
April 7, 2022
Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System
March 15, 2022
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
February 24, 2022
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
February 21, 2022
Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25, 2022
February 9, 2022
Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems
January 18, 2022
Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results
January 9, 2022
Calls in 2022
Decks in 2022
- Q2 2022 Earnings Presentation
Earnings · 22 slides · Aug 5, 2022